A founder called me a few months ago, three weeks before a board meeting, with a fifty-page deck on Vietnamese import classifications. Product registration pathways. Labelling requirements. Which local entity structure to use. Genuinely good work, the kind of research a smart person produces when they have a spreadsheet and an internet connection.
I asked him one question: who is going to sell it?
He had a name. One name. A trading company that had emailed him after a trade show in Singapore, replied within four hours, and offered to be his exclusive distributor for the country. He was about to sign. The regulatory deck was, in effect, a very expensive way of not thinking about that decision.
In twenty years of building and expanding businesses between Europe and Asia, across banking in Hong Kong, consumer hardware manufactured in China, a location-based platform, healthcare across the mainland, and now climate tech, I have never once seen a market entry die on paperwork. Not once. I have seen plenty die quietly, over three to four years, because the first commercial partner was the wrong one and nobody wanted to admit it.
Regulation is a priced-in cost. Partner choice is a permanent one.
Regulation feels like the hard part because it is unfamiliar, it uses language you do not speak, and getting it wrong sounds catastrophic. But it has two properties that make it, operationally, the easy half of the problem.
First, it has answers. Someone has done it before you. There are lawyers, consultants, customs brokers, and competitors whose filings you can read. The cost is knowable in advance: you can get a quote. In my experience across product categories, the fully loaded cost of getting compliant in a new Asian market, testing, registration, labelling, local entity if needed, lands somewhere in a range you can budget and defend to a board. It is a line item. Sometimes it is an ugly line item, and sometimes the answer is “this market is not worth it this year,” which is a perfectly good outcome from a compliance review.
Second, and more importantly, regulation is reversible. If you get the product classification wrong, you refile. If your label is non-compliant, you reprint. Painful, slow, embarrassing, but recoverable within a quarter or two.
Your first distributor is not reversible. That is the whole point.
The moment a partner takes your product into a market, they set three things you do not control afterwards. They set your price point, because the first landed retail price in a market becomes the reference price, and moving it up later is close to impossible. They set your brand position, because whoever they sell to defines who you are: if your premium product enters through a channel that also moves commodity goods, you are a commodity product in that market, whatever your deck says. And they set your relationship with every other potential partner, because in most Asian markets the serious players know each other, and once you are associated with a given distributor you inherit their reputation, good or bad.
Then there is the contract. Even a two-year exclusive with performance clauses will, in practice, take you three years to unwind: a year to realise it is not working, a year of “give us one more season,” and a year to find and onboard a replacement while your original partner still holds inventory and customer relationships. Add the mandatory-agency and termination-compensation rules that exist in several jurisdictions and you can push that longer. Five years from signature to a clean second attempt is a realistic estimate, and in a fast-moving category five years is the whole window.
So one decision costs you a knowable amount of money and can be fixed in a quarter. The other decides your ceiling for half a decade. Guess which one most founders research properly.
Why the partner you can get a meeting with is the wrong one
Here is the mechanism that nobody explains to first-time expanders, and it is close to a law of nature.
The distributors with strong brands, full pipelines, and disciplined sales teams are busy. Their capacity is allocated. Their salespeople have quotas against products they already know how to sell, with established margins and reorder patterns. When an unknown foreign company with no local reference customers approaches them, the rational answer is no, or a very slow maybe. They are not being arrogant. They are protecting a working business.
The distributors who answer your email in four hours, offer exclusivity unprompted, and tell you your product is exactly what the market has been waiting for have spare capacity. That is why they are available. Spare capacity is sometimes the sign of a hungry, well-run challenger, and those partners exist and are wonderful. More often it is the sign of a portfolio that is not performing, a sales team that is underutilised because nothing in the bag is moving, or a trading mentality that makes money on the import margin and treats sell-through as somebody else’s problem.
I have watched this from the other side. When I was building consumer hardware in China and we grew a single product into a range of eight, the partners who wanted us early were the ones who wanted the novelty and the exclusivity, not the ones who wanted to build the category. The good ones made us prove demand first. That was annoying at the time and correct in hindsight.
The trap has a second layer. Exclusivity is the cheapest thing a weak partner can ask for and the most expensive thing you can give. It costs them nothing to hold your rights in a country. If your product sells itself through inbound demand, they collect. If it does not, they lose nothing, because they never allocated real resource to it. You, meanwhile, have locked the market. Your product sits on a price list, gets mentioned when a customer asks for it, and generates just enough volume, maybe fifteen to twenty percent of what the market could absorb, that nobody declares it a failure. That is the shelf. Being shelved is worse than being rejected, because rejection is fast and free.
Run partner selection before you run compliance
Reverse the order. Spend the first eight to twelve weeks of a market entry on commercial discovery, not legal discovery, and do the regulatory work once you know who you are entering with and at what price point. The compliance path sometimes changes depending on the channel anyway, so doing it first can mean doing it twice.
Commercial discovery means talking to ten to fifteen candidate partners, not one. That number matters. With one candidate you are negotiating. With twelve you are choosing, and your questions get sharper because you can compare answers. Finding twelve is work: trade associations, the commercial section of your own embassy, the local sales teams of adjacent (non-competing) brands, and most usefully the customers themselves. Ask five target end customers in that market who they buy from and who actually shows up when there is a problem. Customers will tell you things no partner meeting will.
Then make candidates prove they can sell, not just import. An importer proves logistics. A distributor proves demand creation, and those are completely different companies wearing the same job title. So do not ask for a company profile deck. Ask them to walk you through, name by name and by role, the ten accounts they would approach in the first ninety days and why each one would buy. Ask which of their salespeople would carry your line, what else is in that person’s bag, and what their quota is. Ask to see the sell-through curve of the last new brand they onboarded: how long from signature to first order, and what volume in year one versus what they forecast. A real distributor has these numbers and will share them under an NDA. A trading company will pivot to talking about relationships.
Then pay for a pilot instead of granting exclusivity. This is the single highest-return change you can make to a market entry. Structure a three to six month non-exclusive commercial pilot with a defined volume target, marketing support you fund and control, and a written path to exclusivity if the numbers land. Yes, you pay for it, and yes, the partner will tell you their competitors offer exclusivity from day one. Let them. What you are buying is real data on execution, at a cost that is almost always lower than the cost of one wasted year. Two partners running non-exclusive pilots in parallel in a large market is not a betrayal, it is portfolio management, and any professional distributor understands that perfectly well.
The three questions that expose a partner who will shelve you
I ask these in every partner conversation, and they have never failed me.
“Which of your current brands is underperforming, and what did you do about it?” A partner who runs a real business has a failure and a post mortem. They will tell you about a line that did not move, what they tried, and when they exited. A partner who says everything in their portfolio performs well is either not paying attention to their own numbers or is managing you rather than informing you. Neither is what you want.
“What would make you drop us in eighteen months?” This forces them to describe their economics out loud. The good answer is specific: margin below a threshold, reorder cycles too slow, service load too heavy for the revenue, a category their customers stop asking for. The bad answer is a reassurance that they never drop partners. Loyalty is not the asset you are shopping for. Clear-eyed self-interest is, because self-interest is predictable and you can design around it.
“Who inside your company would own this, and can I speak with them next week?” This is the one that separates real intent from polite interest. If the owner or country manager cannot produce a named person who will carry your product, with an hour in their calendar within a week, you do not have a partner. You have a placeholder on a price list. I have had partner conversations collapse on this question alone, and every time it saved me a year.
None of this makes regulation unimportant. Get it wrong in healthcare, financial services, or anything touching data in China and you will have a genuine crisis. But treat it as what it is: a cost to be priced, scoped, and delegated to people who do it for a living. The question that actually determines whether you have a business in a market five years from now is not which forms you filed. It is whose salesperson wakes up in the morning with your product in their bag, and whether they have any reason to care.
Spend your scarce founder attention there.
I write from twenty years of building businesses between Europe and Asia. If your company is facing this, start a conversation.